Fidelity Investments’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.5K | Buy |
3,139
+722
| +30% | +$5.86K | ﹤0.01% | 4195 |
|
2025
Q1 | $17K | Buy |
2,417
+388
| +19% | +$2.73K | ﹤0.01% | 4293 |
|
2024
Q4 | $15.1K | Buy |
2,029
+504
| +33% | +$3.75K | ﹤0.01% | 4299 |
|
2024
Q3 | $7.52K | Buy |
1,525
+105
| +7% | +$518 | ﹤0.01% | 4513 |
|
2024
Q2 | $7.29K | Sell |
1,420
-70
| -5% | -$359 | ﹤0.01% | 4430 |
|
2024
Q1 | $7.91K | Sell |
1,490
-3,615
| -71% | -$19.2K | ﹤0.01% | 4350 |
|
2023
Q4 | $31.6K | Buy |
5,105
+3,209
| +169% | +$19.9K | ﹤0.01% | 3727 |
|
2023
Q3 | $14.3K | Sell |
1,896
-297
| -14% | -$2.24K | ﹤0.01% | 3971 |
|
2023
Q2 | $21.2K | Buy |
2,193
+166
| +8% | +$1.61K | ﹤0.01% | 3829 |
|
2023
Q1 | $7.65K | Buy |
2,027
+1,921
| +1,812% | +$7.25K | ﹤0.01% | 4234 |
|
2022
Q4 | $687 | Sell |
106
-333
| -76% | -$2.16K | ﹤0.01% | 4708 |
|
2022
Q3 | $4K | Sell |
439
-856
| -66% | -$7.8K | ﹤0.01% | 4400 |
|
2022
Q2 | $13K | Buy |
1,295
+36
| +3% | +$361 | ﹤0.01% | 4022 |
|
2022
Q1 | $15K | Buy |
+1,259
| New | +$15K | ﹤0.01% | 4109 |
|
2013
Q4 | – | Sell |
-632,536
| Closed | -$7.72M | – | 2658 |
|
2013
Q3 | $7.72M | Sell |
632,536
-1,128,854
| -64% | -$13.8M | ﹤0.01% | 2034 |
|
2013
Q2 | $23.3M | Buy |
+1,761,390
| New | +$23.3M | ﹤0.01% | 1595 |
|